Pf bacteriophages hinder sputum antibiotic diffusion via electrostatic binding.

Sputum / microbiology Static Electricity Anti-Bacterial Agents / pharmacology Pseudomonas aeruginosa / drug effects Humans Cystic Fibrosis / metabolism Pseudomonas Infections / drug therapy Tobramycin / pharmacology Diffusion Biofilms / drug effects Bacteriophages

Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
31 May 2024
Historique:
medline: 31 5 2024
pubmed: 31 5 2024
entrez: 31 5 2024
Statut: ppublish

Résumé

Despite great progress in the field, chronic

Identifiants

DOI: 10.1126/sciadv.adl5576 PMID: 38820163
pubmed: 38820163
doi: 10.1126/sciadv.adl5576
doi:

Substances chimiques

Anti-Bacterial Agents 0
Tobramycin VZ8RRZ51VK

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadl5576

Auteurs

Qingquan Chen (Q)

Division of Infectious Diseases and Geographic Medicine, Dept. of Medicine, Stanford University School of Medicine, Beckman Center, 279 Campus Drive, Stanford, CA 94305, USA.
ORCID: 0000-0002-6849-177X

Pam Cai (P)

Department of Chemical Engineering, Stanford University, Stanford, CA, 94305, USA.
ORCID: 0000-0002-0838-0402

Tony Hong Wei Chang (THW)

Division of Infectious Diseases and Geographic Medicine, Dept. of Medicine, Stanford University School of Medicine, Beckman Center, 279 Campus Drive, Stanford, CA 94305, USA.
ORCID: 0000-0003-4227-6163

Elizabeth Burgener (E)

Center for Excellence in Pulmonary Biology, Department of Pediatrics, Stanford University, Stanford, CA 94305, USA.
Children's Hospital of Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA 90027, USA.
ORCID: 0000-0001-8969-6232

Michael J Kratochvil (MJ)

Division of Infectious Diseases and Geographic Medicine, Dept. of Medicine, Stanford University School of Medicine, Beckman Center, 279 Campus Drive, Stanford, CA 94305, USA.
Department of Materials Science and Engineering, Stanford University, 476 Lomita Mall, Stanford, CA 94305, USA.
ORCID: 0000-0002-8845-2524

Aditi Gupta (A)

Division of Infectious Diseases and Geographic Medicine, Dept. of Medicine, Stanford University School of Medicine, Beckman Center, 279 Campus Drive, Stanford, CA 94305, USA.
ORCID: 0009-0001-7188-2536

Aviv Hargill (A)

Division of Infectious Diseases and Geographic Medicine, Dept. of Medicine, Stanford University School of Medicine, Beckman Center, 279 Campus Drive, Stanford, CA 94305, USA.
ORCID: 0009-0007-8121-9301

Patrick R Secor (PR)

Division of Biological Sciences, University of Montana, Missoula, MT 59812, USA.
ORCID: 0000-0001-7123-3037

Josefine Eilsø Nielsen (JE)

Department of Bioengineering, School of Medicine & School of Engineering, Stanford University, Stanford, CA 94305, USA.
Department of Science and Environment, Roskilde University, 4000 Roskilde, Denmark.
ORCID: 0000-0001-9274-5533

Annelise E Barron (AE)

Department of Bioengineering, School of Medicine & School of Engineering, Stanford University, Stanford, CA 94305, USA.
ORCID: 0000-0002-0735-6873

Carlos Milla (C)

Center for Excellence in Pulmonary Biology, Department of Pediatrics, Stanford University, Stanford, CA 94305, USA.
ORCID: 0000-0001-5515-3053

Sarah C Heilshorn (SC)

Department of Materials Science and Engineering, Stanford University, 476 Lomita Mall, Stanford, CA 94305, USA.
ORCID: 0000-0002-9801-6304

Andy Spakowitz (A)

Department of Chemical Engineering, Stanford University, Stanford, CA, 94305, USA.
Department of Materials Science and Engineering, Stanford University, 476 Lomita Mall, Stanford, CA 94305, USA.
ORCID: 0000-0002-0585-1942

Paul L Bollyky (PL)

Division of Infectious Diseases and Geographic Medicine, Dept. of Medicine, Stanford University School of Medicine, Beckman Center, 279 Campus Drive, Stanford, CA 94305, USA.
ORCID: 0000-0003-2499-9448

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Liquides et sécrétions biologiques › Sécrétions corporelles › Expectoration › Pf bacteriophages hinder sputum antibiotic...
questionsmedicales.fr › Phénomènes physiques › Phénomènes magnétiques › Phénomènes électromagnétiques › Électricité › Électricité statique › Pf bacteriophages hinder sputum antibiotic...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Pf bacteriophages hinder sputum antibiotic...
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Pseudomonadaceae › Pseudomonas › Pseudomonas aeruginosa › Pf bacteriophages hinder sputum antibiotic...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Pf bacteriophages hinder sputum antibiotic...
questionsmedicales.fr › Malformations et maladies congénitales, héréditaires et néonatales › Maladies néonatales › Mucoviscidose › Pf bacteriophages hinder sputum antibiotic...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Pseudomonas › Pf bacteriophages hinder sputum antibiotic...
questionsmedicales.fr › Glucides › Hétérosides › Aminosides › Kanamycine › Nébramycine › Tobramycine › Pf bacteriophages hinder sputum antibiotic...
questionsmedicales.fr › Phénomènes chimiques › Diffusion › Pf bacteriophages hinder sputum antibiotic...
questionsmedicales.fr › Phénomènes microbiologiques › Biofilms › Pf bacteriophages hinder sputum antibiotic...
questionsmedicales.fr › Virus › Bactériophages › Pf bacteriophages hinder sputum antibiotic...